focus -WSS

focus

author：hotspot 2025-09-28 21:58:32 - browse：8849

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Carbon Health diabetes program, a test of data

WSS

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

What the US credit downgrade means for the economy, your finances

What is STAT's opinion section for?

Mitch McConnell episode has important public health takeaway

Type 2 diabetes prevention programs work at large scale: study

Breakthrough Alzheimer’s drugs are inaccessible in rural states

focus

focus

hotspot

Medical leaders decry Supreme Court decision on affirmative action

The high personal cost of affirmative action for Black doctors

The high cost of giving birth even with insurance

UnitedHealth sued over use of algorithm in Medicare Advantage plans

BioMarin wins approval for gene therapy to treat hemophilia A

New safety details link Apellis eye drug to rare cases of blindness

Cancer drug shortages should be causing more outrage

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Medical leaders decry Supreme Court decision on affirmative action

Type 2 diabetes prevention programs work at large scale: study

explore

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

The high personal cost of affirmative action for Black doctors

Medicare’s new pay boost for primary care is angering specialists

5 important ways Henrietta Lacks changed medical science

Infectious disease expert Jeanne Marrazzo assumes Fauci role

explore

Wikipedia

focus

hotspot